Developer docs
API playgroundTry for free, no card

Search company profiles

Value8 NV

Full company profile

uuid000mwa4

Namestring
Value8 NV
Legal namestring
Value8 NV
Websiteurl
value8.com
Company typeenum
Public
Founded yearint
2008
Descriptiontext

Value8 NV is a Netherlands-based listed investment company (investeringsmaatschappij) trading on Euronext Amsterdam (ordinary shares ISIN: NL0010661864) that builds and grows publicly tradable Dutch small and medium-sized companies alongside their entrepreneurs and management teams. Founded in 2008 (originally as Exendis NV, which dates to 1939), the firm focuses its capital on two sectors — healthcare and information technology — that benefit from demographic and digitalisation megatrends. Value8 holds controlling or significant stakes in Ctac (66.9%, IT services and Business & Cloud Integrator for SAP and Microsoft), Kersten/Morefield Group (medical aids, including the Naviva Kraamzorg maternity-care acquisition), Almunda Professionals' PIDZ and Novisource (healthcare staffing and financial-sector consultancy), and a 31% interest in Deal Value Group (Brookz/Dealsuite, an online SMB M&A platform). It also holds minority listed equity, including historically in waste-recycler Renewi (exited via Macquarie in 2025).

Value8 generates revenue through dividends from portfolio companies, interest on loans to those companies, realised and unrealised gains on quoted and unquoted investments, and proceeds from divestments (for example, AmsterdamGold sold in September 2024 for €6.2M and Fund Solutions in June 2024 for €2.5M). Operating income was €8.2M (2023) and €9.6M preliminary (2024); net profit reached €7.1M in 2024. The capital base is exceptionally strong — equity crossed €100M for the first time in 2024 to reach €108.9M by H1 2025, with solvency at 93.7% — supporting an unbroken dividend track record since 2011 and the recent €3.50/share mandatory bid that consolidated ownership in Ctac.

Short descriptiontext

Value8 NV is a Dutch listed investment company on Euronext Amsterdam that acquires, finances, and grows small and medium-sized enterprises in healthcare and IT sectors, serving as a public-equity vehicle for investors seeking exposure to a diversified Dutch SMB portfolio.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBussum, Netherlands
HQ citystring
Bussum
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
private equity investments, mid-market equity investments, investment holding company, portfolio management services, Dutch SME growth capital
Industry2 codes
PRIMARYFSANAHAA
Strategic / Balance-Sheet CVC (On-balance-sheet investing)
SECONDARYFSAKAGAB
SME Term Loans & Growth Capital
Financial & Insurance/Lending & Consumer Finance/Small Business & Microenterprise Lending
NAICS code2 codes
  • Funds, Trusts, and Other Financial Vehicles525
  • Other Financial Vehicles52599
SIC code1 code
  • Security Brokers, Dealers & Flotation Companies6211
Product category
Private Equity / Investment Holding
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Dividend income
TypeSubscription Recurring
Description

Value8 receives dividends from its portfolio companies including Ctac, Morefield/Kersten, Almunda Professionals, and others. The company has paid dividends every year since 2011, with total dividends of €3.54 per ordinary share paid from 2011 to 2025.

value8.com
2Capital gains on investments
TypeTransaction Fee
Description

Value8 generates capital gains on both listed and unlisted investments. Realised gains on quoted investments were €4.3 million and on unquoted investments €0.4 million in 2023. Total reële waarde stijging (fair value increase) was €3.9 million in 2024.

value8.com
3Interest income
TypeUsage Based
Description

Value8 earns interest on loans provided to portfolio companies and other receivables. Interest income rose from €0.79 million in 2023 to €1.21 million in 2024.

value8.com
4Exit proceeds from desinvestments
TypeTransaction Fee
Description

Value8 exits investments through trade sales or IPOs. Sold AmsterdamGold in September 2024 for €6.2 million (achieving ~9.5% annual return since 2011). Sold Fund Solutions in June 2024 for €2.5 million.

value8.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Others, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Value8 NV is a Dutch listed investment company that builds growing listed SMB companies together with entrepreneurs and managers. The company acquires equity stakes (majority and minority) in Dutch SMB companies primarily in healthcare and information technology, providing growth capital and strategic support. Value8 earns returns through dividends, interest income, capital gains, and exits via trade sales or IPOs, and has paid annual dividends every year since 2011.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • NAV per share grew from €0.41 (September 2008) to €11.31 (2025), a 1400% increase
+3 more records
Product overview1 text field

Value8 NV is an investment company (investeringsmaatschappij) listed on Euronext Amsterdam that builds growing listed SME companies with excellent entrepreneurs and managers. The company focuses on long-term value creation in the healthcare and information technology sectors. Value8's portfolio consists of investment holdings rather than a unified product platform. Key portfolio companies include Ctac (IT services with SAP/Microsoft solutions and the XV Retail Suite), Kersten/Morefield Group (medical aids), PIDZ (healthcare professionals platform), and Almunda Professionals (professional services including Novisource and ICE).

Product and service2 records
1Value8 Investment Management Services
CategoryInvestment Management
Description

Long-term equity investment management services that build growing listed SMB companies together with entrepreneurs and managers. Value8 acquires majority or minority stakes in Dutch companies and provides growth capital, strategic guidance, and acquisition financing.

2Ctac
Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierMinorTypeOthersAnnounced on2025-09-05
Description

ABN AMRO Bank N.V. acted as the paying and exchange agent (betaal- en verwisselkantoor) for Value8's mandatory public bid on Ctac shares. ABN AMRO provides corporate broking services and was designated to distribute the offer document free of charge to those who requested it, in coordination with Value8's registered office in Bussum.

Strategic tierMinorTypeOthersAnnounced on2024-01-29
Description

BK Group (a Value8 portfolio company) agreed to sell 100% of its shares in Fund Solutions S.C.A. to Atoz Services S.A., a Luxembourg-based professional services firm providing business and tax services to entities managed by alternative funds and corporate clients. The transaction was completed above book value and had a small positive effect on Value8's NAV per share. Completion was subject to CSSF approval. This was a one-time exit transaction; Fund Solutions was subsequently desinvested.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

HAL Trust is a Dutch-listed holding company that invests in mid-market companies across sectors including healthcare, IT services, and industrial goods. Closest structural analog to Value8: listed permanent-capital vehicle with concentrated Dutch/Benelux deal sourcing and long-hold strategy.

TypeBroad incumbent
Description

3i Group is a UK-listed PE firm with large mid-market buyout and infrastructure strategies. Structural analog (listed-PE model) but operates at far greater scale and focuses on larger pan-European/global deals rather than Dutch SMBs.

TypeDirect peer
Description

Kinnevik is a Swedish-listed investment company with growth-stage and listed-equity exposure focused on consumer internet, financial services, and healthcare. Comparable structural model with listed-permanent-capital approach, though tilted toward earlier-stage consumer/internet rather than Dutch SMB buyouts.

TypeDirect peer
Description

Gimv is a Belgian-listed investment company investing in mid-cap companies across healthcare, technology, and consumer. Same structural model as Value8 (listed permanent-capital PE/VC) and directly comparable in mid-market healthcare and IT focus, with somewhat larger portfolio scale.

TypeDirect peer
Description

DBAG is a German-listed private equity firm focused on mid-market companies in industrial, IT, and healthcare sectors. Same mid-market listed-PE structure as Value8, with comparable average ticket sizes and a similar buy-and-hold-to-delist approach in target companies.

TypeDirect peer
Description

Sofina is a Belgian-listed investment company focused on growth-stage investments in consumer, healthcare, and digital transformation. Shares Value8's listed long-term holding structure, thematic healthcare/IT focus, and minority-to-control ownership style in mid-sized European companies.

TypeBroad incumbent
Description

CVC is a global large-cap private equity firm that listed on Euronext Amsterdam in 2024. Shares Value8's Euronext-Amsterdam listing and PE business model, but operates at vastly greater scale with global deal sourcing rather than Dutch SMB focus.

TypeDirect peer
Description

Exor is an Italian-listed holding company with controlling stakes in Stellantis, Ferrari, and other large enterprises. Operates Value8's same listed-vehicle structure for principal investing, but at far larger scale and focused on global blue-chip companies rather than Dutch SMBs.

TypeDirect peer
Description

Eurazeo is a French-listed global investment company with mid-market PE, growth, and private debt strategies. Shares Value8's listed-permanent-capital model and focus on mid-sized European companies, though larger and more diversified by sector and geography.

TypeRegional player
Description

Waterland is a privately-held Benelux-focused mid-market private equity firm investing in healthcare, IT, and business services. Directly competes with Value8 for the same Dutch/Benelux SMB deal pool but operates a traditional closed-end fund structure rather than the listed-permanent-capital model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Value8 NV

Private Equity / Investment Holdingvalue8.com

Value8 NV is a Dutch listed investment company on Euronext Amsterdam that acquires, finances, and grows small and medium-sized enterprises in healthcare and IT sectors, serving as a public-equity vehicle for investors seeking exposure to a diversified Dutch SMB portfolio.

What Value8 NV does

Value8 NV is a Netherlands-based listed investment company (investeringsmaatschappij) trading on Euronext Amsterdam (ordinary shares ISIN: NL0010661864) that builds and grows publicly tradable Dutch small and medium-sized companies alongside their entrepreneurs and management teams. Founded in 2008 (originally as Exendis NV, which dates to 1939), the firm focuses its capital on two sectors — healthcare and information technology — that benefit from demographic and digitalisation megatrends. Value8 holds controlling or significant stakes in Ctac (66.9%, IT services and Business & Cloud Integrator for SAP and Microsoft), Kersten/Morefield Group (medical aids, including the Naviva Kraamzorg maternity-care acquisition), Almunda Professionals' PIDZ and Novisource (healthcare staffing and financial-sector consultancy), and a 31% interest in Deal Value Group (Brookz/Dealsuite, an online SMB M&A platform). It also holds minority listed equity, including historically in waste-recycler Renewi (exited via Macquarie in 2025).

Value8 generates revenue through dividends from portfolio companies, interest on loans to those companies, realised and unrealised gains on quoted and unquoted investments, and proceeds from divestments (for example, AmsterdamGold sold in September 2024 for €6.2M and Fund Solutions in June 2024 for €2.5M). Operating income was €8.2M (2023) and €9.6M preliminary (2024); net profit reached €7.1M in 2024. The capital base is exceptionally strong — equity crossed €100M for the first time in 2024 to reach €108.9M by H1 2025, with solvency at 93.7% — supporting an unbroken dividend track record since 2011 and the recent €3.50/share mandatory bid that consolidated ownership in Ctac.

Value8 NV firmographics

Firmographics
Name
Value8 NV
Legal name
Value8 NV
Website
https://value8.com
Company type
Public
Founded year
2008
Operating status
Operating
Headcount range
11–50 employees
Short description
Value8 NV is a Dutch listed investment company on Euronext Amsterdam that acquires, finances, and grows small and medium-sized enterprises in healthcare and IT sectors, serving as a public-equity vehicle for investors seeking exposure to a diversified Dutch SMB portfolio.
Ownership category
akta.pro rank

Value8 NV industry classification

Industry
Product category
Private Equity / Investment Holding
NAICS
Funds, Trusts, and Other Financial Vehicles (525), Other Financial Vehicles (52599)
SIC
Security Brokers, Dealers & Flotation Companies (6211)
akta.pro industry
PRIMARYFSANAHAA
Strategic / Balance-Sheet CVC (On-balance-sheet investing)
SECONDARYFSAKAGAB
SME Term Loans & Growth Capital
Financial & Insurance/Lending & Consumer Finance/Small Business & Microenterprise Lending

Keywords

  • Private equity investments
  • Mid-market equity investments
  • Investment holding company
  • Portfolio management services
  • Dutch SME growth capital

Where Value8 NV is headquartered

Location

Headquarters

HQ city
Bussum
HQ country
Netherlands
HQ region
Europe

Offices1 record

Markets served

Value8 NV business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Others, Marketing or Sales, Infrastructure

Revenue model

  1. Dividend income: Value8 receives dividends from its portfolio companies including Ctac, Morefield/Kersten, Almunda Professionals, and others. The company has paid dividends every year since 2011, with total dividends of €3.54 per ordinary share paid from 2011 to 2025.
  2. Capital gains on investments: Value8 generates capital gains on both listed and unlisted investments. Realised gains on quoted investments were €4.3 million and on unquoted investments €0.4 million in 2023. Total reële waarde stijging (fair value increase) was €3.9 million in 2024.
  3. Interest income: Value8 earns interest on loans provided to portfolio companies and other receivables. Interest income rose from €0.79 million in 2023 to €1.21 million in 2024.
  4. Exit proceeds from desinvestments: Value8 exits investments through trade sales or IPOs. Sold AmsterdamGold in September 2024 for €6.2 million (achieving ~9.5% annual return since 2011). Sold Fund Solutions in June 2024 for €2.5 million.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Value8 NV product offering

Product offering

Core offering

Value8 NV is a Dutch listed investment company that builds growing listed SMB companies together with entrepreneurs and managers. The company acquires equity stakes (majority and minority) in Dutch SMB companies primarily in healthcare and information technology, providing growth capital and strategic support. Value8 earns returns through dividends, interest income, capital gains, and exits via trade sales or IPOs, and has paid annual dividends every year since 2011.

Product overview

Value8 NV is an investment company (investeringsmaatschappij) listed on Euronext Amsterdam that builds growing listed SME companies with excellent entrepreneurs and managers. The company focuses on long-term value creation in the healthcare and information technology sectors. Value8's portfolio consists of investment holdings rather than a unified product platform. Key portfolio companies include Ctac (IT services with SAP/Microsoft solutions and the XV Retail Suite), Kersten/Morefield Group (medical aids), PIDZ (healthcare professionals platform), and Almunda Professionals (professional services including Novisource and ICE).

Differentiator

Problem solved

Functional benefit

Products and services

  • Value8 Investment Management Services Long-term equity investment management services that build growing listed SMB companies together with entrepreneurs and managers. Value8 acquires majority or minority stakes in Dutch companies and provides growth capital, strategic guidance, and acquisition financing.
  • Ctac

Quantifiable outcome

  • NAV per share grew from €0.41 (September 2008) to €11.31 (2025), a 1400% increase
  • +3 more outcomes

Companies that use Value8 NV

Customer profile

Named customers4 records

Segments1 record

Ideal customer profiles2 records

Value8 NV technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Value8 NV partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered minor.

  • ABN AMRO Bank N.V.minorOthers · 5 September 2025ABN AMRO Bank N.V. acted as the paying and exchange agent (betaal- en verwisselkantoor) for Value8's mandatory public bid on Ctac shares. ABN AMRO provides corporate broking services and was designated to distribute the offer document free of charge to those who requested it, in coordination with Value8's registered office in Bussum.
  • Atoz Services S.A.minorOthers · 29 January 2024BK Group (a Value8 portfolio company) agreed to sell 100% of its shares in Fund Solutions S.C.A. to Atoz Services S.A., a Luxembourg-based professional services firm providing business and tax services to entities managed by alternative funds and corporate clients. The transaction was completed above book value and had a small positive effect on Value8's NAV per share. Completion was subject to CSSF approval. This was a one-time exit transaction; Fund Solutions was subsequently desinvested.

Scale indicators14 records

Recent moves8 records

Expansion highlights5 records

Value8 NV competitors and assessment

Company assessment

Direct peers

  • HAL Holding / HAL Trust: HAL Trust is a Dutch-listed holding company that invests in mid-market companies across sectors including healthcare, IT services, and industrial goods. Closest structural analog to Value8: listed permanent-capital vehicle with concentrated Dutch/Benelux deal sourcing and long-hold strategy.
  • Kinnevik: Kinnevik is a Swedish-listed investment company with growth-stage and listed-equity exposure focused on consumer internet, financial services, and healthcare. Comparable structural model with listed-permanent-capital approach, though tilted toward earlier-stage consumer/internet rather than Dutch SMB buyouts.
  • Gimv: Gimv is a Belgian-listed investment company investing in mid-cap companies across healthcare, technology, and consumer. Same structural model as Value8 (listed permanent-capital PE/VC) and directly comparable in mid-market healthcare and IT focus, with somewhat larger portfolio scale.
  • Deutsche Beteiligungs AG (DBAG): DBAG is a German-listed private equity firm focused on mid-market companies in industrial, IT, and healthcare sectors. Same mid-market listed-PE structure as Value8, with comparable average ticket sizes and a similar buy-and-hold-to-delist approach in target companies.
  • Sofina: Sofina is a Belgian-listed investment company focused on growth-stage investments in consumer, healthcare, and digital transformation. Shares Value8's listed long-term holding structure, thematic healthcare/IT focus, and minority-to-control ownership style in mid-sized European companies.
  • Exor N.V. Exor is an Italian-listed holding company with controlling stakes in Stellantis, Ferrari, and other large enterprises. Operates Value8's same listed-vehicle structure for principal investing, but at far larger scale and focused on global blue-chip companies rather than Dutch SMBs.
  • Eurazeo: Eurazeo is a French-listed global investment company with mid-market PE, growth, and private debt strategies. Shares Value8's listed-permanent-capital model and focus on mid-sized European companies, though larger and more diversified by sector and geography.

Broad incumbents

  • 3i Group: 3i Group is a UK-listed PE firm with large mid-market buyout and infrastructure strategies. Structural analog (listed-PE model) but operates at far greater scale and focuses on larger pan-European/global deals rather than Dutch SMBs.
  • CVC Capital Partners: CVC is a global large-cap private equity firm that listed on Euronext Amsterdam in 2024. Shares Value8's Euronext-Amsterdam listing and PE business model, but operates at vastly greater scale with global deal sourcing rather than Dutch SMB focus.

Regional players

  • Waterland Private Equity: Waterland is a privately-held Benelux-focused mid-market private equity firm investing in healthcare, IT, and business services. Directly competes with Value8 for the same Dutch/Benelux SMB deal pool but operates a traditional closed-end fund structure rather than the listed-permanent-capital model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Value8 NV social profiles

Digital presence

Value8 NV financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Value8 NV leadership team

Management profile

Number of profiles

Profiles4 records

Value8 NV subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Value8 NV funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Value8 NV M&A and investment

M&A and investment

M&A1 record

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Value8 NV

What does Value8 NV do?

Value8 NV is a Dutch listed investment company that builds growing listed SMB companies together with entrepreneurs and managers. The company acquires equity stakes (majority and minority) in Dutch SMB companies primarily in healthcare and information technology, providing growth capital and strategic support. Value8 earns returns through dividends, interest income, capital gains, and exits via trade sales or IPOs, and has paid annual dividends every year since 2011.

Is Value8 NV a public or private company?

Value8 NV is a public company. It is classified as public and is currently operating.

When was Value8 NV founded?

Value8 NV was founded in 2008. It employs 11 to 50 people.

Where is Value8 NV based?

Value8 NV is headquartered in Bussum, Netherlands, in the Europe region.

How does Value8 NV make money?

Four revenue lines are on record. Dividend income is the primary driver. The others are capital gains on investments, interest income and exit proceeds from desinvestments.

Who are Value8 NV's main competitors?

Direct peers on record are HAL Holding / HAL Trust, Kinnevik, Gimv, Deutsche Beteiligungs AG (DBAG), Sofina, Exor N.V. and Eurazeo. Broad incumbents are 3i Group and CVC Capital Partners. Waterland Private Equity is listed as a regional player.

Does Value8 NV have an API?

No public API is recorded for Value8 NV.

What industry is Value8 NV in?

Value8 NV's product category is Private Equity / Investment Holding. Its primary akta.pro industry code is FSANAHAA, Strategic / Balance-Sheet CVC (On-balance-sheet investing), with a secondary code of FSAKAGAB, SME Term Loans & Growth Capital. Its NAICS code is 525 and its SIC code is 6211.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales